NorDiag ASA has on 16 March 2007 completed the acquisition of 100% of the shares in Genpoint AS. As consideration for the Genpoint shares, the Company has today resolved to issue a total of 9,799,982 new shares in NorDiag to the Genpoint shareholders at a subscription price of NOK 8.50 per share. The new shares were subscribed for at the completion of the acquisition.

NorDiag has on 16 March 2007 also resolved to issue the 3,839,938 new shares that were allocated under the private placement announced on 2 March 2007, and which was carried out in connection with the entering into of the purchase agreement for the Genpoint shares. The subscription price for the new shares is NOK 8.50 per share. The purpose of the private placement was to secure funding to finance roll-out of new products and faster growth.

As a result of the above share issues, NorDiag’s share capital has been increased to NOK 3,714,734.50, divided on 37,147,345 shares each of a nominal value of NOK 0.10.